Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice

Brain Research

Volumn 706, Issue 1, 1996, Pages 13-20

  Fang, Fan ^a   Tao, Qing ^a   Abood, Mary ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase; Cannabinoid; CP 55,940; Mouse; Receptor down regulation; Tolerance

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CEREBELLUM; CONTROLLED STUDY; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0343724969     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01113-7     Document Type: Article

References (36)

1. Devane, W.A., Dysarz F.A.. Johnson M.R., Melvin L.S. and Howlett A.C., Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34 (1988) 605-613.
2. Matsuda, L., Cloning of the cannabinoid receptor gene, Neurosci. Facts, 3 (1992) 53.
3. Munro, S., Thomas K.L. and Abu-Shaar M., Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365 (1993) 61-64.
4. Devane, W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A. and Mechoulam R., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258 (1992) 1946-1949.
5. Howlett, A.C., Johnson M.R., Melvin L.S. and Milne G.M., Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model, Mol. Pharmacol., 33 (1988) 297-302.
6. Mackie, K. and Hille B., Cannabinoids inhibit N-type calcium channels in neurobalstoma-glioma cells, Proc. Natl. Acad. Sci. USA, 89 (1992) 3825-3829.
7. Rinaldi-Carmona, M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C. and Le Fur G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett., 350 (1994) 240-244.
8. McMillan, D.E., Dewey W.L. and Harris L.S., Characteristics of tetrahydrocannabinol tolerance, Ann. N.T. Acad. Sci. 191 (1971) 83-99.
9. Compton, D.R., Dewey, W.L. and Martin, B.R., Cannabis dependence and tolerance production, In C.K. Erickson, M.A. Javors and W. W. Morgan (Eds.), Addiction Potential of Abused Drugs and Drug Classes, Vol. 9, The Hayworth Press, Inc., Binghampton, 1990, pp. 129-147.
10. Pertwee, R.G., Tolerance to and dependence on psychotropic cannabinoids. In J.A. Pratt (Ed.), The Biological Bases of Drug Tolerance and Dependence, Academic Press, New York, 1991, pp. 231-263.
11. Pertwee, R., Stevenson, L. and Griffin, G., Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide, Br. J. Pharmacol., 110 (1993) 1483-1490.
12. Little, P.J., Compton, D.R., Johnson, M.R., Melvin, L.S. and Martin, B.R., Pharmacology and stereoselectivity of structurally novel cannabinoids in mice, J. Pharmacol. Exp. Ther., 247 (1988) 1046-1051.
13. 9-THC, CP 55,940 and WIN 55,212, J. Pharmacol. Exp. Ther., 271 (1994) 1383-1390.
14. 9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs, J. Pharmacol. Exp. Ther., 196 (1976) 128-144.
15. Oviedo, A., Glowa, J. and Herkenham, M., Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res., 616 (1993) 293-302.
16. 9-tetrahydrocannabinol treatment, Pharmacol. Biochem. Behav., 47 (1994) 33-40.
17. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in the whole brain, Pharmacol. Biochem. Behav., 46 (1993) 575-579.
18. Pertwee, R.G., The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice, Br. J. Pharmacol., 46 (1972) 753-763.
19. Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johns on M.R. and Martin, B.R., Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities, J. Pharmacol. Exp. Ther., 265 (1993) 218-226.
20. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 12 (1976) 248-254.
21. Pacheco, M., Childers, S.R., Arnold, R., Casiano, F. and Ward, S.J., Aminoalkylindoles: Actions on specific G-protein-linked receptors, J. Pharmacol Exp. Ther., 257 (1991) 170-183.
22. 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes, Life Sci., 48 (1991) 1133-1141.
23. Chomczysnski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
24. Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning: A laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989, pp. 7.46-7.50.
25. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner T.I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature. 346 (1990) 561-564.
26. Kaymakcalan, S., Tolerance to and dependence on cannabis, Bull. Narc., 25 (1973) 39-47.
27. Scarpace, P.J. and Abrass, I.B., Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist, J. Pharmacol. Exp. Ther., 223 (1982) 327-331.
28. Cioffi, C. and El-Fakahany, E., Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: Selective loss of agonist low-affinity and pirenzepine high-affinity binding sites., J. Pharmacol. Exp. Ther., 238 (1986) 916-923.
29. Creese, I. and Sibley, D., Receptor adaptations to centrally acting drugs, Annu. Rev. Pharm. Tox., 21 (1981) 357-391.
30. Tietz, E., Rosenberg, H. and Chiu, T., Autoradiographic localization of benzodiazepine receptor downregulation, J. Pharmacol. Exp. Ther., 236 (1986) 284-292.
31. Werling, L., McMahon, P. and Cox, B., Selective changes in mu opioid receptor properties induced by chronic morphine exposure, Proc. Natl. Acad Sci. USA, 86 (1989) 6393-6397.
32. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors, Brain Res., 544 (1991) 145-149.
33. Howlett, A.C., Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes, Mol. Pharmacol., 27 (1985) 429-436.
34. Felder, C.C., Veluz, J.S., Williams, H.L., Briley, E.M. and Matsuda L.A., Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones, Mol. Pharmacol., 42 (1992) 838-845.
35. Pacheco, M.A., Ward, S.J. and Childers, S.R., Identification of cannabinoid receptors in cultures of rat cerebellar granule cells, Brain Res., 603 (1993) 102.
36. Bidaut-Russell, M., Devane, W.A. and Howlett, A.C., Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain, J. Neurochem., 55 (1990) 21-26.